2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertensionMarc Humbert, Ekkehard Grünig, Riccardo Asteggiano et al.|European Heart Journal|2022Cited by 3.6k
Benefits of omalizumab as add‐on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATEMarc Humbert, K. Surrey, Richard Beasley et al.|Allergy|2004Cited by 1.1k
Pathologic assessment of vasculopathies in pulmonary hypertensionGiuseppe G. Pietra, Rubin M. Tuder, Frédérique Capron et al.|Journal of the American College of Cardiology|2004Cited by 713
New Formula for Predicting Mean Pulmonary Artery Pressure Using Systolic Pulmonary Artery PressureD. S. Chemla, Philippe Hervé, Vincent Castelain et al.|CHEST Journal|2004Cited by 497
Identification of rare sequence variation underlying heritable pulmonary arterial hypertensionStefan Gräf, Nicholas W. Morrell, Dan F. Stein et al.|Nature Communications|2018Cited by 382